Delivery Order SPE2DB20D3303-SPE2DB24FA1BJ
Award Date
7/16/24
Potential Completion Date
8/6/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is a delivery order for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2024 and does not have a set-aside designation, indicating open competition. Additionally, AmerisourceBergen holds a significant...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of June 5, 2024. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is a delivery order for VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication. The contract has a firm fixed-price pricing type and an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a medical product, with a completion date of March 17, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,761.80 firm fixed-price delivery order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication. The contract has an ultimate completion date of November 8, 2024. This award appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 Delivery Order contract is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, and has a completion date of July 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,408.24, is a delivery order for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, with a completion date of December 18, 2024. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The $12,960.30 firm fixed price delivery order has an ultimate completion date of October 11, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary...